"European equity markets are expected to open steady as investors brace for earnings from some major European names," commented Hargreaves Lansdown's Matt Britzman. "The FTSE 100 is following ...

(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myeloma, the third most common type of blood cancer.

Wealth net flows improves 21% to GBP7.71 billion in the first nine months of 2024 from GBP6.37 billion. Retirement sales leapt 67% to GBP7.28 billion from GBP4.36 billion and Protection & Health sales ...